Deckers Outdoor Corp vs Novartis AG — how do they compare? Deckers Outdoor Corp trades at $106.98 (market cap $14.97B), while Novartis AG trades at $150.42 (market cap $293.74B). The key difference: Novartis AG is far larger — about 19.6× Deckers Outdoor Corp's market cap, and Novartis AG pays a 3.09% dividend while Deckers Outdoor Corp pays none. Which is the better fit depends on your goals.
| DECK | NVS | |
|---|---|---|
Market Cap | $14.97B | $293.74B |
Sector | Consumer Cyclical | Health |
52-Week High | $123.91 | $168.62 |
52-Week Low | $79.54 | $113.50 |
Enterprise Value | $13.44B | $333.76B |
Dividend Yield | — | 3.09% |
Trailing returns across standard periods
Latest headlines on both assets
Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Read more on DECK →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →